{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:45:50Z","timestamp":1793497550342,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-26975-1","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T10:58:28Z","timestamp":1764327508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of bromelain supplementation on disease activity and quality of life in patients with ulcerative colitis: a randomized, triple-blind, placebo-controlled study"],"prefix":"10.1038","volume":"15","author":[{"given":"Pedram","family":"Delgarm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Mokhtare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser","family":"Ebrahimi Daryani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamile","family":"Abolghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Tayebeh","family":"Rahideh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"26975_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.chc.2010.01.007","volume":"19","author":"E Szigethy","year":"2010","unstructured":"Szigethy, E., McLafferty, L. & Goyal, A. Inflammatory bowel disease. Child. Adolesc. Psychiatr Clin. N Am. 19, 301\u2013318. https:\/\/doi.org\/10.1016\/j.chc.2010.01.007 (2010). ix.","journal-title":"Child. Adolesc. Psychiatr Clin. N Am."},{"key":"26975_CR2","doi-asserted-by":"crossref","unstructured":"Guan, Q. A comprehensive review and update on the pathogenesis of inflammatory bowel disease. J.  Immunol. Res. 2019 (2019).","DOI":"10.1155\/2019\/7247238"},{"key":"26975_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","volume":"474","author":"B Khor","year":"2011","unstructured":"Khor, B., Gardet, A. & Xavier, R. J. Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307\u2013317 (2011).","journal-title":"Nature"},{"key":"26975_CR4","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra0804647","volume":"361","author":"C Abraham","year":"2009","unstructured":"Abraham, C. & Cho, J. H. Inflammatory bowel disease. N Engl. J. Med. 361, 2066\u20132078. https:\/\/doi.org\/10.1056\/NEJMra0804647 (2009).","journal-title":"N Engl. J. Med."},{"key":"26975_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.25122\/jml-2018-0075","volume":"12","author":"SS Seyedian","year":"2019","unstructured":"Seyedian, S. S., Nokhostin, F. & Malamir, M. D. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J. Med. Life. 12, 113 (2019).","journal-title":"J. Med. Life"},{"key":"26975_CR6","doi-asserted-by":"publisher","unstructured":"Guan, Q. A. & Comprehensive review and update on the pathogenesis of inflammatory bowel disease. J.  Immunol. Res. 2019 7247238. https:\/\/doi.org\/10.1155\/2019\/7247238 (2019).","DOI":"10.1155\/2019\/7247238"},{"key":"26975_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.25122\/jml-2018-0075","volume":"12","author":"SS Seyedian","year":"2019","unstructured":"Seyedian, S. S., Nokhostin, F. & Malamir, M. D. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J. Med. Life. 12, 113\u2013122. https:\/\/doi.org\/10.25122\/jml-2018-0075 (2019).","journal-title":"J. Med. Life"},{"key":"26975_CR8","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/s0140-6736(12)60150-0","volume":"380","author":"I Ord\u00e1s","year":"2012","unstructured":"Ord\u00e1s, I., Eckmann, L., Talamini, M., Baumgart, D. C. & Sandborn, W. J. Ulcerative colitis. Lancet 380, 1606\u20131619. https:\/\/doi.org\/10.1016\/s0140-6736(12)60150-0 (2012).","journal-title":"Lancet"},{"key":"26975_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1053\/j.sempedsurg.2017.10.003","volume":"26","author":"YR Yu","year":"2017","unstructured":"Yu, Y. R. & Rodriguez, J. R. Clinical presentation of Crohn\u2019s, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes. Semin Pediatr. Surg. 26, 349\u2013355. https:\/\/doi.org\/10.1053\/j.sempedsurg.2017.10.003 (2017).","journal-title":"Semin Pediatr. Surg."},{"key":"26975_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","volume":"18","author":"GG Kaplan","year":"2021","unstructured":"Kaplan, G. G. & Windsor, J. W. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat. Reviews Gastroenterol. Hepatol. 18, 56\u201366 (2021).","journal-title":"Nat. Reviews Gastroenterol. Hepatol."},{"key":"26975_CR11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1053\/j.gastro.2019.01.002","volume":"156","author":"S Coward","year":"2019","unstructured":"Coward, S. et al. Past and future burden of inflammatory bowel diseases based on modeling of population-based data. Gastroenterology 156, 1345\u20131353 (2019).","journal-title":"Gastroenterology"},{"key":"26975_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.cgh.2019.06.030","volume":"18","author":"PG Kotze","year":"2020","unstructured":"Kotze, P. G. et al. Progression of inflammatory bowel diseases throughout Latin America and the caribbean: a systematic review. Clin. Gastroenterol. Hepatol. 18, 304\u2013312 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"26975_CR13","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.14309\/ajg.0000000000002687","volume":"119","author":"S Coward","year":"2024","unstructured":"Coward, S. et al. Forecasting the incidence and prevalence of inflammatory bowel disease: a Canadian nationwide analysis. Official J. Am. Coll. Gastroenterology| ACG. 119, 1563\u20131570 (2024).","journal-title":"Official J. Am. Coll. Gastroenterology| ACG"},{"key":"26975_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12876-021-01745-1","volume":"21","author":"M Olfatifar","year":"2021","unstructured":"Olfatifar, M. et al. The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: a modeling study. BMC Gastroenterol. 21, 204 (2021).","journal-title":"BMC Gastroenterol."},{"key":"26975_CR15","first-page":"86","volume":"5","author":"KM Shirazi","year":"2013","unstructured":"Shirazi, K. M. et al. Epidemiological and clinical characteristics of inflammatory bowel disease in patients from Northwestern Iran. Middle East. J. Dig. Dis. 5, 86\u201392 (2013).","journal-title":"Middle East. J. Dig. Dis."},{"key":"26975_CR16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/s0140-6736(23)00966-2","volume":"402","author":"C Le Berre","year":"2023","unstructured":"Le Berre, C., Honap, S. & Peyrin-Biroulet, L. Ulcerative colitis. Lancet 402, 571\u2013584. https:\/\/doi.org\/10.1016\/s0140-6736(23)00966-2 (2023).","journal-title":"Lancet"},{"key":"26975_CR17","first-page":"210","volume":"28","author":"A Triantafyllidi","year":"2015","unstructured":"Triantafyllidi, A., Xanthos, T., Papalois, A. & Triantafillidis, J. K. Herbal and plant therapy in patients with inflammatory bowel disease. Ann. Gastroenterol. 28, 210\u2013220 (2015).","journal-title":"Ann. Gastroenterol."},{"key":"26975_CR18","doi-asserted-by":"publisher","unstructured":"Hikisz, P. & Bernasinska-Slomczewska, J. Beneficial properties of bromelain. Nutrients 13 https:\/\/doi.org\/10.3390\/nu13124313 (2021).","DOI":"10.3390\/nu13124313"},{"key":"26975_CR19","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1007\/PL00000936","volume":"58","author":"H Maurer","year":"2001","unstructured":"Maurer, H. Bromelain: biochemistry, Pharmacology and medical use. Cell. Mol. Life Sci. CMLS. 58, 1234\u20131245 (2001).","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"26975_CR20","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/ptr.6848","volume":"35","author":"N Tahvilian","year":"2021","unstructured":"Tahvilian, N. et al. Effects of saffron supplementation on oxidative\/antioxidant status and severity of disease in ulcerative colitis patients: A randomized, double-blind, placebo-controlled study. Phytother Res. 35, 946\u2013953. https:\/\/doi.org\/10.1002\/ptr.6848 (2021).","journal-title":"Phytother Res."},{"key":"26975_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3325\/cmj.2009.50.105","volume":"50","author":"K Krleza-Jeri\u0107","year":"2009","unstructured":"Krleza-Jeri\u0107, K. & Lemmens, T. 7th revision of the declaration of helsinki: good news for the transparency of clinical trials. Croat Med. J. 50, 105\u2013110. https:\/\/doi.org\/10.3325\/cmj.2009.50.105 (2009).","journal-title":"Croat Med. J."},{"key":"26975_CR22","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s11655-016-2521-2","volume":"22","author":"CM Ley","year":"2016","unstructured":"Ley, C. M., Ni, Q., Liao, X., Gao, H. L. & Robinson, N. Bromelain and cardiovascular risk factors in diabetes: an exploratory randomized, placebo controlled, double blind clinical trial. Chin. J. Integr. Med. 22, 728\u2013737. https:\/\/doi.org\/10.1007\/s11655-016-2521-2 (2016).","journal-title":"Chin. J. Integr. Med."},{"key":"26975_CR23","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.3389\/fimmu.2017.01468","volume":"8","author":"Z Zhou","year":"2017","unstructured":"Zhou, Z. et al. Inhibition of epithelial TNF-\u03b1 receptors by purified fruit Bromelain ameliorates intestinal inflammation and barrier dysfunction in colitis. Front. Immunol. 8, 1468. https:\/\/doi.org\/10.3389\/fimmu.2017.01468 (2017).","journal-title":"Front. Immunol."},{"key":"26975_CR24","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1007\/s10620-015-3727-4","volume":"60","author":"M Torki","year":"2015","unstructured":"Torki, M. et al. Vitamin D deficiency associated with disease activity in patients with inflammatory bowel diseases. Dig. Dis. Sci. 60, 3085\u20133091. https:\/\/doi.org\/10.1007\/s10620-015-3727-4 (2015).","journal-title":"Dig. Dis. Sci."},{"key":"26975_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.47176\/mjiri.35.3","volume":"35","author":"F Farsi","year":"2021","unstructured":"Farsi, F. et al. Effects of coenzyme Q10 on health-related quality of life, clinical disease activity and blood pressure in patients with mild to moderate ulcerative colitis: a randomized clinical trial. Med. J. Islam Repub. Iran. 35, 3. https:\/\/doi.org\/10.47176\/mjiri.35.3 (2021).","journal-title":"Med. J. Islam Repub. Iran."},{"key":"26975_CR26","unstructured":"Gholamrezaei, A., Haghdani, S., Shemshaki, H., Tavakoli, H. & Emami, M. H. Linguistic validation of the inflammatory bowel disease questionnaire-short form (IBDQ-9) in Iranian population. J.  Isfahan Med. School 28 (2011)."},{"key":"26975_CR27","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1572-0241.2005.40641.x","volume":"100","author":"PD Higgins","year":"2005","unstructured":"Higgins, P. D., Schwartz, M., Mapili, J. & Zimmermann, E. M. Is endoscopy necessary for the measurement of disease activity in ulcerative colitis? Am. J. Gastroenterol. 100, 355\u2013361. https:\/\/doi.org\/10.1111\/j.1572-0241.2005.40641.x (2005).","journal-title":"Am. J. Gastroenterol."},{"key":"26975_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1572-0241.2004.04071.x","volume":"99","author":"F Casellas","year":"2004","unstructured":"Casellas, F., Alcal\u00e1, M. J., Prieto, L., Mir\u00f3, J. R. & Malagelada, J. R. Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire. Am. J. Gastroenterol. 99, 457\u2013461. https:\/\/doi.org\/10.1111\/j.1572-0241.2004.04071.x (2004).","journal-title":"Am. J. Gastroenterol."},{"key":"26975_CR29","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1249\/01.Mss.0000074446.02192.14","volume":"35","author":"M Aadahl","year":"2003","unstructured":"Aadahl, M. & J\u00f8rgensen, T. Validation of a new self-report instrument for measuring physical activity. Med. Sci. Sports Exerc. 35, 1196\u20131202. https:\/\/doi.org\/10.1249\/01.Mss.0000074446.02192.14 (2003).","journal-title":"Med. Sci. Sports Exerc."},{"key":"26975_CR30","doi-asserted-by":"publisher","first-page":"7656","DOI":"10.3390\/molecules26247656","volume":"26","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Pineapple leaf phenols attenuate DSS-Induced colitis in mice and inhibit inflammatory damage by targeting the NF-\u03baB pathway. Molecules 26, 7656 (2021).","journal-title":"Molecules"},{"key":"26975_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.clim.2005.04.011","volume":"116","author":"LP Hale","year":"2005","unstructured":"Hale, L. P., Greer, P. K., Trinh, C. T. & Gottfried, M. R. Treatment with oral Bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease. Clin. Immunol. 116, 135\u2013142. https:\/\/doi.org\/10.1016\/j.clim.2005.04.011 (2005).","journal-title":"Clin. Immunol."},{"key":"26975_CR32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1128\/iai.70.1.86-95.2002","volume":"70","author":"TL Mynott","year":"2002","unstructured":"Mynott, T. L., Crossett, B. & Prathalingam, S. R. Proteolytic Inhibition of Salmonella enterica serovar typhimurium-induced activation of the mitogen-activated protein kinases ERK and JNK in cultured human intestinal cells. Infect. Immun. 70, 86\u201395. https:\/\/doi.org\/10.1128\/iai.70.1.86-95.2002 (2002).","journal-title":"Infect. Immun."},{"key":"26975_CR33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.clim.2007.11.002","volume":"126","author":"JE Onken","year":"2008","unstructured":"Onken, J. E., Greer, P. K., Calingaert, B. & Hale, L. P. Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro. Clin. Immunol. 126, 345\u2013352. https:\/\/doi.org\/10.1016\/j.clim.2007.11.002 (2008).","journal-title":"Clin. Immunol."},{"key":"26975_CR34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.clim.2008.02.015","volume":"128","author":"DJ Fitzhugh","year":"2008","unstructured":"Fitzhugh, D. J., Shan, S., Dewhirst, M. W. & Hale, L. P. Bromelain treatment decreases neutrophil migration to sites of inflammation. Clin. Immunol. 128, 66\u201374. https:\/\/doi.org\/10.1016\/j.clim.2008.02.015 (2008).","journal-title":"Clin. Immunol."},{"key":"26975_CR35","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1002\/ibd.21320","volume":"16","author":"LP Hale","year":"2010","unstructured":"Hale, L. P., Chichlowski, M., Trinh, C. T. & Greer, P. K. Dietary supplementation with fresh pineapple juice decreases inflammation and colonic neoplasia in IL-10-deficient mice with colitis. Inflamm. Bowel Dis. 16, 2012\u20132021. https:\/\/doi.org\/10.1002\/ibd.21320 (2010).","journal-title":"Inflamm. Bowel Dis."},{"key":"26975_CR36","doi-asserted-by":"publisher","unstructured":"Chakraborty, A. J. et al. Bromelain a potential bioactive compound: A comprehensive overview from a pharmacological perspective. Life (Basel). 11 https:\/\/doi.org\/10.3390\/life11040317 (2021).","DOI":"10.3390\/life11040317"},{"key":"26975_CR37","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10787-019-00595-4","volume":"27","author":"I Bjarnason","year":"2019","unstructured":"Bjarnason, I., Sission, G. & Hayee, B. H. A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and crohn\u2019s disease. Inflammopharmacology 27, 465\u2013473 (2019).","journal-title":"Inflammopharmacology"},{"key":"26975_CR38","doi-asserted-by":"publisher","unstructured":"Erol Do\u011fan, \u00d6., \u00c7elik, K., Ba\u015f, K. E., Alan, M., \u00c7a\u011f\u0131n, Y. F. & E. H. & Effects of mediterranean diet, curcumin, and resveratrol on mild-to-moderate active ulcerative colitis: a multicenter randomized clinical trial. Nutrients 16 https:\/\/doi.org\/10.3390\/nu16101504 (2024).","DOI":"10.3390\/nu16101504"},{"key":"26975_CR39","doi-asserted-by":"publisher","first-page":"1357914","DOI":"10.3389\/fmed.2024.1357914","volume":"11","author":"J Lin","year":"2024","unstructured":"Lin, J. et al. The effectiveness and safety of lifestyle medicine and integrative therapies in inflammatory arthritis: an umbrella review using a hierarchical evidence gathering approach. Front. Med. (Lausanne). 11, 1357914. https:\/\/doi.org\/10.3389\/fmed.2024.1357914 (2024).","journal-title":"Front. Med. (Lausanne)"},{"key":"26975_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/08820130802083622","volume":"37","author":"JR Huang","year":"2008","unstructured":"Huang, J. R., Wu, C. C., Hou, R. C. & Jeng, K. C. Bromelain inhibits lipopolysaccharide-induced cytokine production in human THP-1 monocytes via the removal of CD14. Immunol. Invest. 37, 263\u2013277. https:\/\/doi.org\/10.1080\/08820130802083622 (2008).","journal-title":"Immunol. Invest."},{"key":"26975_CR41","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1021\/jf052390k","volume":"54","author":"RC Hou","year":"2006","unstructured":"Hou, R. C., Chen, Y. S., Huang, J. R. & Jeng, K. C. Cross-linked Bromelain inhibits lipopolysaccharide-induced cytokine production involving cellular signaling suppression in rats. J. Agric. Food Chem. 54, 2193\u20132198. https:\/\/doi.org\/10.1021\/jf052390k (2006).","journal-title":"J. Agric. Food Chem."},{"key":"26975_CR42","first-page":"325","volume":"10","author":"H Barth","year":"2005","unstructured":"Barth, H., Guseo, A. & Klein, R. In vitro study on the immunological effect of Bromelain and trypsin on mononuclear cells from humans. Eur. J. Med. Res. 10, 325\u2013331 (2005).","journal-title":"Eur. J. Med. Res."},{"key":"26975_CR43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1089\/cbr.1994.9.253","volume":"9","author":"L Desser","year":"1994","unstructured":"Desser, L., Rehberger, A. & Paukovits, W. Proteolytic enzymes and amylase induce cytokine production in human peripheral blood mononuclear cells in vitro. Cancer Biother. 9, 253\u2013263. https:\/\/doi.org\/10.1089\/cbr.1994.9.253 (1994).","journal-title":"Cancer Biother"},{"key":"26975_CR44","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1113\/jphysiol.2013.253518","volume":"591","author":"Y Feng","year":"2013","unstructured":"Feng, Y. & Teitelbaum, D. H. Tumour necrosis factor\u2013induced loss of intestinal barrier function requires TNFR1 and TNFR2 signalling in a mouse model of total parenteral nutrition. J. Physiol. 591, 3709\u20133723. https:\/\/doi.org\/10.1113\/jphysiol.2013.253518 (2013).","journal-title":"J. Physiol."},{"key":"26975_CR45","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1053\/j.gastro.2013.04.011","volume":"145","author":"L Su","year":"2013","unstructured":"Su, L. et al. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Gastroenterology 145, 407\u2013415. https:\/\/doi.org\/10.1053\/j.gastro.2013.04.011 (2013).","journal-title":"Gastroenterology"},{"key":"26975_CR46","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.4049\/jimmunol.149.12.3809","volume":"149","author":"LP Hale","year":"1992","unstructured":"Hale, L. P. & Haynes, B. F. Bromelain treatment of human T cells removes CD44, CD45RA, E2\/MIC2, CD6, CD7, CD8, and leu 8\/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation. J. Immunol. 149, 3809\u20133816 (1992).","journal-title":"J. Immunol."},{"key":"26975_CR47","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.4049\/jimmunol.163.5.2568","volume":"163","author":"TL Mynott","year":"1999","unstructured":"Mynott, T. L., Ladhams, A., Scarmato, P. & Engwerda, C. R. Bromelain, from pineapple stems, proteolytically blocks activation of extracellular regulated kinase-2 in T cells. J. Immunol. 163, 2568\u20132575 (1999).","journal-title":"J. Immunol."},{"key":"26975_CR48","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/s0065-230x(08)60101-3","volume":"71","author":"D Naor","year":"1997","unstructured":"Naor, D., Sionov, R. V. & Ish-Shalom, D. CD44: structure, function, and association with the malignant process. Adv. Cancer Res. 71, 241\u2013319. https:\/\/doi.org\/10.1016\/s0065-230x(08)60101-3 (1997).","journal-title":"Adv. Cancer Res."},{"key":"26975_CR49","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fimmu.2015.00201","volume":"6","author":"S Misra","year":"2015","unstructured":"Misra, S., Hascall, V. C., Markwald, R. R. & Ghatak, S. Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer. Front. Immunol. 6, 201. https:\/\/doi.org\/10.3389\/fimmu.2015.00201 (2015).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26975-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26975-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26975-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T10:58:30Z","timestamp":1764327510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26975-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["26975"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26975-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42799"}}